Free Tool · Checker

Peptide Legal Status Checker (US)

Pick a peptide and your state. We'll show federal scheduling, FDA Category 1/2/3 status, telehealth availability where you live, recent enforcement actions (2024-2026), and which legal sourcing channels are still standing as of April 2026.

1. Pick a peptide

2. Your state

FDA Category 2 (excluded from compounding)California: Moderate scrutinyNot DEA-scheduled. FDA jurisdiction.

BPC-157 in California

Also: Body Protection Compound-157 / PL 14736

Placed on FDA's Category 2 bulks list in November 2023. Licensed 503A and 503B compounding pharmacies cannot legally compound BPC-157 for human use. No DEA scheduling — it is not a controlled substance — but it is also not a legal drug.

Telehealth: available in California

Available in California but legally fragile: Some clinics still prescribe through grey-market channels — legally fragile.

Legal sourcing channels (April 2026)

FDA-approved brand pharmacy
Closed
No FDA-approved brand exists.
503A compounding pharmacy
Closed
Excluded by Category 2 designation (Nov 2023).
503B outsourcing facility
Closed
Same Category 2 exclusion applies.
Telehealth (compounded)
Limited
Some clinics still prescribe through grey-market channels — legally fragile.
Research chemical vendor
Open
Sold by US research vendors (Pure Rawz, Amino Asylum, Swole AF). Labeled 'not for human use'.
International import (personal)
Limited
Personal-import enforcement is uneven; FDA can detain shipments.

California state-specific notes

Moderate scrutinyTelehealth: Yes

Cal. Bus. & Prof. Code 2242.1 requires good-faith exam (telehealth video counts). DEA tighter on shipping.

Recent enforcement actions (2024-2026)

Aug 2024FDA
Multiple Instagram sellers
Joint FDA/FTC sweep targeting unlawful disease claims.
Mar 2025FTC
Peptide Warriors LLC
$1.2M settlement for marketing BPC-157 as an FDA-approved injury treatment.
Jan 2026FDA
Three compounding pharmacies
Warning letters for continued BPC-157 compounding post Cat 2 ruling.

Want the full BPC-157 profile?

Dosing, half-life, study summaries, and stack pairings.

Open profile →

Legal & medical disclaimer: This checker reflects publicly available regulatory data as of April 2026 and is informational only — not legal or medical advice. Federal and state law evolves quickly. Peptides marketed as research chemicals are not FDA-approved for human use. Consult a licensed clinician and verify current law in your jurisdiction before any decision.

Last updated: April 2026.

Get legal status alerts first

One email when a peptide changes category, a state passes a new restriction, or a major enforcement action lands.